Describe the etiology of pain among HF patients and examine the relationship between pain and QoL.
Background:
Little is known about the etiology of pain in patients with heart failure (HF) and the impact it has on quality of life (QoL).
Methods:
A prospective cohort study of outpatients with NYHA Class II or III HF were surveyed at baseline and at three-month follow-up. The study was conducted in Heart Failure clinics affiliated with a large, urban, academic medical center.
Results:
Of 104 patients that completed a baseline survey, 73 (70%) completed a follow-up survey. At baseline, 48% of patients reported having pain the previous week. Patients on prescription pain medication (n = 16) had more severe pain (Mean = 4.5 vs. 2.6; p = 0.001). Physician documented pain etiologies included: musculoskeletal (50%, n = 16), cardiac (22%, n = 7), and headache/neurological (22%, n = 7). Linear regression revealed that significant contributions to QoL included HF Class (p = 0.0001), dyspnea (p = 0.0001), and depression (p = 0.01). Pain was not independently associated with QoL (p = 0.17), but moderately correlated with depression (r = 0.49). Although 15% (n = 11) of patients reported a clinically meaningful improvement in pain scores, it was not associated with improvements in QoL (χ2 = 1.6, p = 0.2).
Discussion:
Pain is prevalent and persistent, due largely to non-cardiac causes. Although pain did not predict QOL, it was associated with depression, which did adversely affect QoL. Clinicians should screen for and treat both symptoms.
Get full access to this article
View all access options for this article.
References
1.
GoAS, MozaffarianD, RogerVL, et al.: Heart disease and stroke statistics—2014 update: A report from the American Heart Association. Circulation, 2014; 129:e28–e292.
2.
RogerVL, GoAS, Lloyd-JonesDM, et al.: Heart disease and stroke statistics—2011 update: A report from the American Heart Association. Circulation, 2011; 123:e18–e209.
3.
StewartS, MacIntyreK, HoleDJ, et al.: More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail, 2001; 3:315–322.
4.
SchockenDD, BenjaminEJ, FonarowGC, et al.: Prevention of heart failure: A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 2008; 117:2544–2565.
5.
DicksteinK, Cohen-SolalA, FilippatosG, et al.: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J, 2008; 29:2388–2442.
6.
Heart Failure Society of America. Disease management in heart failure. J Card Fail, 2006; 12:e58–e69.
7.
HuntSA: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005; 46:e1–e82.
8.
PantilatSZ, O'RiordanDL, DibbleSL, LandefeldCS: Longitudinal assessment of symptom severity among hospitalized elders diagnosed with cancer, heart failure, and chronic obstructive pulmonary disease. J Hosp Med, 2012; 7:567–572.
9.
BekelmanDB, HavranekEP, BeckerDM, et al.: Symptoms, depression, and quality of life in patients with heart failure. J Card Fail, 2007; 13:643–648.
10.
BlindermanCD, HomelP, BillingsJA, et al.: Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage, 2008; 35:594–603.
11.
GoebelJR, DoeringLV, ShugarmanLR, et al.: Heart failure: The hidden problem of pain. J Pain Symptom Manage, 2009; 38:698–707.
12.
GoodlinSJ, WingateS, PresslerSJ, et al.: Investigating pain in heart failure patients: Rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study. J Card Fail, 2008; 14:276–282.
13.
GoodlinSJ, WingateS, AlbertNM, et al.: Investigating pain in heart failure patients: The pain assessment, incidence, and nature in heart failure (PAIN-HF) study. J Card Fail, 2012; 18:776–783.
14.
GottM, BarnesS, ParkerC, et al.: Predictors of the quality of life of older people with heart failure recruited from primary care. Age Ageing, 2006; 35:172–177.
15.
The Criteria Committee of the New York Heart Association: Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. Boston, MA: Little Brown & Co., 1994.
16.
CleelandCS, RyanKM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore, 1994; 23:129–138.
17.
DworkinRH, TurkDC, WyrwichKW, et al.: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain, 2008; 9:105–121.
18.
OrmeJG, ReisJ, HerzEJ: Factorial and discriminant validity of the Center for Epidemiological Studies Depression (CES-D) scale. J Clin Psychol, 1986; 42:28–33.
19.
ScheinRL, KoenigHG: The Center for Epidemiological Studies-Depression (CES-D) Scale: Assessment of depression in the medically ill elderly. Int J Geriatr Psychiatry, 1997; 12:436–446.
20.
Lesman-LeegteI, JaarsmaT, SandermanR, et al.: Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail, 2006; 8:634–640.
21.
JacobsonNS, TruaxP: Clinical Significance: A Statistical Approach to Defining Meaningful Change in Psychotherapy Research. Washington, DC: American Psychological Association, 1992.
22.
BorgGA: Psychophysical bases of perceived exertion. Med Sci Sports Exerc, 1982; 14:377–381.
23.
BauseweinC, FarquharM, BoothS, et al.: Measurement of breathlessness in advanced disease: A systematic review. Respir Med, 2007; 101:399–410.
24.
RectorTS, CohnJN: Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J, 1992; 124:1017–1025.
25.
RectorTS, TschumperlinLK, KuboSH, et al.: Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail, 1995; 1:201–206.
26.
IBM Corp.: IBM SPSS Statistics for Macintosh, Version 22.0 [computer program]. Armonk, NY: IBM Corp., 2013.
27.
QuillTE, AbernethyAP: Generalist plus specialist palliative care—creating a more sustainable model. N Engl J Med, 2013; 368:1173–1175.
28.
ManningJS, JacksonWC: Depression, pain, and comorbid medical conditions. J Clin Psychiatry, 2013; 74:e03.
O'ConnorAB, DworkinRH: Treatment of neuropathic pain: An overview of recent guidelines. Am J Med, 2009; 122(10 Suppl):S22–S32.
31.
GoodlinSJ: Sadness in heart failure: What is a clinician to do?. J Am Coll Cardiol, 2010; 56:700–701.
32.
O'ConnorCM, JiangW, KuchibhatlaM, et al: Safety and efficacy of sertraline for depression in patients with heart failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol, 2010; 56:692–699.
EvangelistaLS, LombardoD, MalikS, et al.: Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure. J Card Fail, 2012; 18:894–899.
35.
Institute of Medicine: Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington DC: The National Academics Press, 2014.
